For the past seven years, Rock Health has gathered digital health CEOs, from seed stage to round E (E!?), to hear how their colleagues address the challenges that, for the most part, everyone in the room has faced – or will soon.
Care Resource, a local provider of skilled home health nursing in Rhode Island and Southern Massachusetts, was acquired by Encompass Health, a publicly traded company focused on inpatient and home-based care that helps patients achieve life-changing results. The transaction expands Encompass Health's home health footprint into Rhode Island and will enhance its existing Massachusetts operations.
After 20 years and more than 325 health care deals closed, we’ve seen a lot. Here are some things we’ve learned. If someone says, “it’s business, nothing personal,” it isn’t, and it is. Nothing good can happen between a letter of intent and closing.
A large number of hospitals and health systems are expanding their home health businesses through partnering or acquiring home health agencies. From 2016 to 2018, 177 of these hospitals or health systems acquired home health care companies.
The signs are out there.And they’re pointing the way towards a possible resurgence in at-risk youth mergers and acquisitions activity.Although there are many variations on the theme, conditions are ripe for a rise in consolidation activity in health care services when some or all of the following market factors are in play.
The temporary ban on the Medicare Provider Enrollment Moratoria became effective last month. It's expected that this move by CMS will allow agencies to improve patient access to home-based care. Managing Director Mark Kulik spoke with Home Health Care News regarding the positive impact this will have in the industry. “I think competition is what’s
Overheard at JP Morgan Every January, thousands of health care investors and bankers and providers, oh my, flock to Union Square in San Francisco for Healthcarepalooza, otherwise known as the JP Morgan Health Care Conference. While some come bearing a golden ticket to attend the actual meeting, the overwhelming number of “attendees” are party crashers
In an interview with The DealRoom, Director of Finance Steve Garbon shared some intriguing insight on future M&A activity, deal disasters, and unrealistic valuation expectations. If we have to address those concerns before going to market, our nicheness allows us to have a comprehensive database of transactions for each of our sectors…so we have cold hard
Two mega healthcare and pharmacy deals are in the works, which shows that bigger companies continue to get bigger. The CVS-Aetna merger and the Cigna-Express Scripts merger further consolidate the market, a trend Reg Blackburn notes has been happening for a long time. He explains more in an interview with Drug Topics. “I think it’s part
Drug Channels, using data from The Braff Group, provided information regarding the specialty pharmacy deals in 2018. As more transactions occurred in 2018 compared to 2017 (and more deals in 2017 compared to 2016), the market remains very active and will continue to see more exits in 2019. Click here to read
